Commonwealth Coat of Arms of Australia

PB 18 of 2023

National Health (Weighted average disclosed price – April 2023 reduction day) Amendment Determination 2023

I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated: 24 February 2023

Adriana Platona

First Assistant Secretary

Technology Assessment and Access Division

Department of Health and Aged Care

1 Name of Instrument

(1) This instrument is the National Health (Weighted average disclosed price – April 2023 reduction day) Amendment Determination 2023.

(2) This instrument may also be cited as PB 18 of 2023.

2 Commencement

This instrument commences on the day after it is registered.

3 Authority

This instrument is made under subsection 99ADB(4) of the National Health Act 1953.

4 Amendments to PB 132 of 2022

Schedule 1 amends the National Health (Weighted average disclosed price – April 2023 reduction day) Determination 2022 (PB 132 of 2022).

Schedule 1 Amendments

[1] Schedule 1

omit:

165

Infliximab

Solution for injection 120 mg in 1 mL pre-filled pen

Injection

Remsima SC

$203.34

[2] Schedule 2

omit:

1499	Infliximab	Powder for I.V. infusion 100 mg	Injection	Inflectra	$195.95
1500	Infliximab	Powder for I.V. infusion 100 mg	Injection	Remicade	$195.95
1501	Infliximab	Powder for I.V. infusion 100 mg	Injection	Renflexis	$195.95

insert:

1499	Infliximab	Powder for I.V. infusion 100 mg	Injection	Inflectra	$261.96
1500	Infliximab	Powder for I.V. infusion 100 mg	Injection	Remicade	$261.96
1501	Infliximab	Powder for I.V. infusion 100 mg	Injection	Renflexis	$261.96
1501A	Infliximab	Solution for injection 120 mg in 1 mL pre-filled pen	Injection	Remsima SC	$271.83